Romy Cohen

Title: Romy Cohen: Innovator in Transferrin Receptor-Binding Molecules

Introduction

Romy Cohen is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biotechnology, particularly in the development of molecules that can bind to transferrin receptors. His work has implications for transporting pharmaceutical and diagnostic agents into cells, especially in the context of diseases like cancer.

Latest Patents

Cohen holds a patent for "Transferrin receptor-binding molecules, conjugates thereof and their uses." This invention focuses on Variable Domain of Camelid Heavy Chain-only (VHH) molecules that bind to transferrin receptors. The applications of this technology are vast, including the potential to deliver therapeutic agents directly into cells and organs affected by pathological conditions.

Career Highlights

Throughout his career, Romy Cohen has worked with several prominent organizations. He has been associated with Vect-Horus, a company known for its innovative approaches in drug delivery systems. Additionally, he has contributed to research at Université d'Aix-Marseille, where he has collaborated with other researchers to advance the field of molecular biology.

Collaborations

Cohen has worked alongside notable colleagues, including Marion David and Michel Khrestchatisky. Their collaborative efforts have furthered the understanding and application of transferrin receptor-binding technologies.

Conclusion

Romy Cohen's innovative work in the field of transferrin receptor-binding molecules showcases his commitment to advancing medical science. His contributions have the potential to significantly impact therapeutic delivery systems in the treatment of various diseases.